Vanguard Global Advisers
KZR

Vanguard Global Advisers’s Kezar Life Sciences KZR Stock Holding History

Vanguard Global Advisers’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,737
Closed -$12.9K – 3699
2026
Q1 		$12.9K Buy
+1,737
New +$11.3K ﹤0.01% 3437

Vanguard Global Advisers's KZR Position: Q2 2026 in Review

Vanguard Global Advisers sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 1,737 shares — an estimated $12.9K sold.

Vanguard Global Advisers first reported a position in KZR in Q1 2026 and held it in 1 quarter. The position peaked at $12.9K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

  • Vanguard Global Advisers reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Vanguard Global Advisers sold 1,737 Kezar Life Sciences shares in Q2 2026, an estimated $12.9K.
  • Vanguard Global Advisers first reported a position in Kezar Life Sciences in Q1 2026 and held it in 1 quarter.
  • Vanguard Global Advisers's Kezar Life Sciences position peaked at $12.9K in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.